Taking action on smoking and health
ASH Scotland today welcomed the fact that the first medicines licence has been awarded for a novel nicotine delivery device.
Reacting to the MHRA (Medicines and Healthcare products Regulatory Agency) decision on the Voke inhaler, Sheila Duffy, Chief Executive of ASH Scotland, said:
“The harm caused by tobacco use is so great that we need to explore all the available options for supporting people to quit smoking. We know that the majority of smokers want to quit and hope that novel nicotine devices prove to be a useful addition to the options available to them.
“We have always been clear that this new market needs to be regulated. Medicines regulation is a strong and appropriate way of organising the sale of addictive products.
“We should treat this product on its own merits, separately from the tobacco company interests behind it. Yet we must remain alert to the major part played in this market by tobacco companies, which long ago decided to put profits before the health and well-being of their customers.
“British American Tobacco’s professed interest in harm reduction will be a sham for as long as the company continues to produce and actively promote millions of cigarettes which they know cause cancer, heart disease, stroke, dementia and arthritis amongst their customers. Until that attitude changes and they stop opposing legitimate health measures, they should retain their pariah status, excluded from decision-making on public health and clearly identified as a major part of the problem.”
Action on Smoking & Health (Scotland) (ASH Scotland) is a registered Scottish charity (SC 010412) and a company limited by guarantee(Scottish company no 141711). The registered office is 8 Frederick Street, Edinburgh EH2 2HB.
ASH Scotland acknowledges with thanks the support of the British Heart Foundation and the Scottish Government in developing our website.